Table 1.
Patient characteristics
| Patient characteristics N = 34 (%) | |
|---|---|
| Age: | |
| Range: 27–76 year | |
| Median: 58.5 year | |
| M/F: | 20 (59)/ 14 (41) |
| ECOG PS | |
| 0: | 14 (41) |
| 1: | 20 (59) |
| Cancer type | |
| Colon: | 8 (23) |
| Lung: | 2 (6) |
| Pancreas: | 2 (6) |
| Prostate: | 1 (3) |
| Sarcomaa: | 16 (47) |
| Otherb: | 5 (15) |
| Stage at study entry | |
| II: | 1 (3) |
| III: | 1 (3) |
| IV: | 31 (91) |
| Unknown: | 1 (3) |
| Time from diagnosisc | |
| Range: 0.6–13.9 years | |
| Median: 4.34 years | |
| Prior chemotherapy | 34 (100) |
| Range: 1–27 | |
| Median: 7.5 | |
aLiposarcoma, n = 4; Leiomyosarcoma, n = 3; High grade sarcoma NOS, n = 2; and one each of the following: adenosarcoma of the uterus, chondrosarcoma, desmoplastic small round cell tumor, Ewing’s Sarcoma/PNET, pleomorphic sarcoma, rhabdomyosarcoma, and spindle cell sarcoma
bOther tumor types include adrenal cell carcinoma, ovarian cancer, pulmonary carcinoid tumor, squamous cell carcinoma of tongue, thymoma
cYears since diagnosis = (Date informed consent first signed—date of initial diagnosis + 1) / 365.25